Kevin K. Roggin to Disease-Free Survival
This is a "connection" page, showing publications Kevin K. Roggin has written about Disease-Free Survival.
Connection Strength
0.266
-
Limitations of ampullectomy in the treatment of nonfamilial ampullary neoplasms. Ann Surg Oncol. 2005 Dec; 12(12):971-80.
Score: 0.055
-
Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity. Am Surg. 2021 Nov; 87(11):1752-1759.
Score: 0.042
-
Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. J Surg Res. 2020 01; 245:577-586.
Score: 0.036
-
Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. J Surg Res. 2019 01; 233:154-162.
Score: 0.033
-
Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2014 Dec; 156(6):1504-10; discussion 1510-1.
Score: 0.026
-
Is multimodality therapy necessary for the management of pure myxoid liposarcomas? A multi-institutional series of pure myxoid liposarcomas of the extremities and torso. J Surg Oncol. 2015 Feb; 111(2):146-51.
Score: 0.025
-
Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study. Ann Surg. 2014 May; 259(5):960-5.
Score: 0.025
-
Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors. J Gastrointest Surg. 2014 Mar; 18(3):457-62; discussion 462-3.
Score: 0.024